相关实验视频
Updated: Jul 12, 2025

10:20
In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
20.8K
阿米特里普提林抑制支气管收缩,并直接促进气道的扩张
Paulina Hempel1,2, Virag Klein1,2, Anna Michely1,2
1Department of Pediatrics, Medical Faculty, RWTH Aachen, University Hospital Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.
Respiratory research
|November 1, 2023
概括
抗抑郁药物阿米林抑制了急性支气管收缩,并扩大了预先收缩的气道. 这种药物显示出治疗喘的潜力,通过解决呼吸道过敏反应和TH2-过敏表型,特别是当吸入时.
科学领域:
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
- 免疫学 免疫学 免疫学
背景情况:
- 标准的喘治疗包括短期和长期治疗,包括吸入的皮质类固醇和支气管扩展剂.
- 抗抑郁药物阿米林降低了喘中TH2-表型的调节,部分是通过抑制酸胺基酶 (ASM).
- 这项研究调查了阿米特利普提林对喘中急性支气管收缩的非免疫作用.
研究的目的:
- 调查阿米特利普提林在急性支气管收缩中的非免疫作用.
- 评估阿米丁林对预先收缩的呼吸道的支气管扩张作用.
- 为了比较阿米特利普提林与标准支气管扩展剂的疗效.
主要方法:
- 来自小鼠,大鼠,几内亚猪和人类的精确切割肺切片 (PCLS) 用于测试阿米特利普提林对各种媒介诱导的支气管收缩的影响.
- 隔离透气肺 (IPL) 和带有flexiVent设置的体内小鼠模型被用于评估阿米林的全身和吸入管理.
- 气道扩张在老鼠PCLS中进行了评估,并与IBMX和salbutamol进行了比较.
主要成果:
- 艾米特里普提林在物种之间抑制了PCLS中由乙胆,血清素和组胺诱导的支气管收缩.
- 阿米特利普提林的抑制作用独立于ASM缺乏症.
- 系统性和吸入性阿米氨酸都降低了小鼠的呼吸道阻力,而吸入性给药显示了乙胆诱导的收缩明显改善.
- 阿米特利普提林的支气管扩张效果与IBMX和萨尔布塔摩尔的组合相美.
结论:
- 阿米提林有效地抑制了急性支气管收缩,并在预先收缩的气道中诱导支气管膨胀.
- 该药物具有作为喘治疗剂的潜力,针对TH2-过敏表型和急性气道过敏反应.
- 吸入阿米特利普提林可能为喘提供特别有效的治疗策略.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
278
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
278
Antiasthma Drugs: Methylxanthines
242
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
242
Antiasthma Drugs: Muscarinic Receptor Antagonists
316
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
316
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
864
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
864
Antihypertensive Drugs: Types of β-Blockers
701
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
701
Adrenergic Agonists: Therapeutic Classification
837
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
837

